| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Current Ratio | 2.52 | % | -19% |
| Debt-to-equity | -103 | % | +0.6% |
| Return On Equity | 14.8 | % | |
| Return On Assets | -574 | % | -838% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Entity Common Stock, Shares Outstanding | 57.1M | shares | 0% |
| Common Stock, Shares, Outstanding | 57.1M | shares | 0% |
| Entity Public Float | 1.71M | USD | 0% |
| Weighted Average Number of Shares Outstanding, Basic | 57.1M | shares | 0% |
| Weighted Average Number of Shares Outstanding, Diluted | 57.1M | shares | 0% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Research and Development Expense | 0 | USD | |
| Operating Income (Loss) | -435K | USD | -37.4% |
| Net Income (Loss) Attributable to Parent | -511K | USD | -722% |
| Earnings Per Share, Basic | -0.01 | USD/shares |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | 6.38K | USD | -97.4% |
| Assets, Current | 15.1K | USD | -94.3% |
| Assets | 15.1K | USD | -94.3% |
| Accounts Payable, Current | 810K | USD | +1.48% |
| Accrued Liabilities, Current | 1.77M | USD | +4.78% |
| Liabilities, Current | 3.67M | USD | +7.66% |
| Liabilities | 3.67M | USD | +7.66% |
| Retained Earnings (Accumulated Deficit) | 47.3M | USD | +1.09% |
| Stockholders' Equity Attributable to Parent | -3.65M | USD | -16.3% |
| Liabilities and Equity | 15.1K | USD | -94.3% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Net Cash Provided by (Used in) Operating Activities | -89.6K | USD | -118% |
| Net Cash Provided by (Used in) Financing Activities | 45K | USD | |
| Net Cash Provided by (Used in) Investing Activities | 69K | USD | -81% |
| Common Stock, Shares Authorized | 250M | shares | 0% |
| Common Stock, Shares, Issued | 57.1M | shares | 0% |
| Common Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | -89.6K | USD | -223% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | 6.38K | USD | -97.4% |
| Deferred Tax Assets, Valuation Allowance | 17.4M | USD | +0.77% |
| Deferred Tax Assets, Operating Loss Carryforwards | 17.4M | USD | +0.77% |
| Additional Paid in Capital | 42.3M | USD | 0% |
| Interest Expense | 75.9K | USD | -2.21% |